LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
|
Basic information |
| Metabolite name | LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) |
 | HMDB0010402 |
 |
C04230 |
 |
53480473 |
| Synonyms | LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)) |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) |
| HMDB0010402 |
|
C04230 |
|
53480473 |
| Synonyms | LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)) |
| No. of studies | 3 |
|
Relationship between LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M687 | Type2 | Kai-Xin-San group vs. depression group | Serum | Human | Up |
| Study M712 | Type1 | depression group vs. control group | Hippocampus | Cynomolgus monkey | Up |